Literature DB >> 19500647

Neuroprotection (and lack of neuroprotection) afforded by a series of noble gases in an in vitro model of neuronal injury.

Noorulhuda Jawad1, Maleeha Rizvi, Jianteng Gu, Olar Adeyi, Guocai Tao, Mervyn Maze, Daqing Ma.   

Abstract

Xenon-induced neuroprotection has been well studied both in vivo and in vitro. In this study, the neuroprotective properties of the other noble gases, namely, krypton, argon, neon and helium, were explored in an in vitro model of neuronal injury. Pure neuronal cultures, derived from foetal BALB/c mice cortices, were provoked into injury by oxygen and glucose deprivation (OGD). Cultures were exposed to either nitrogen hypoxia or noble gas hypoxia in balanced salt solution devoid of glucose for 90min. The cultures were allowed to recover in normal culture medium for a further 24h in nitrogen or noble gas. The effect of noble gases on cell reducing ability in the absence of OGD was also investigated. Cell reducing ability was quantified via an MTT assay and expressed as a ratio of the control. The OGD caused a reduction in cell reducing ability to 0.56+/-0.04 of the control in the absence of noble gas (p<0.001). Like xenon (0.92+/-0.10; p<0.001), neuroprotection was afforded by argon (0.71+/-0.05; p<0.01). Neon and krypton did not have a protective effect under our experimental conditions. Helium had a detrimental effect on the cells. In the absence of OGD, krypton reduced the reducing ability of uninjured cells to 0.84+/-0.09 (p<0.01), but argon showed an improvement in reducing ability to 1.15+/-0.11 (p<0.05). Our data suggest that the cheap and widely available noble gas argon may have potential as a neuroprotectant for the future.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19500647     DOI: 10.1016/j.neulet.2009.05.069

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  41 in total

Review 1.  [Neuroprotection by noble gases: New developments and insights].

Authors:  A V Fahlenkamp; R Rossaint; M Coburn
Journal:  Anaesthesist       Date:  2015-11       Impact factor: 1.041

2.  Specifics of pulmonary gas exchange after replacing the inert components of inspired mixtures.

Authors:  V P Nikolaev
Journal:  Dokl Biol Sci       Date:  2015-05-05

Review 3.  Noble gases as cardioprotectants - translatability and mechanism.

Authors:  Kirsten F Smit; Nina C Weber; Markus W Hollmann; Benedikt Preckel
Journal:  Br J Pharmacol       Date:  2015-01-12       Impact factor: 8.739

4.  Modulation by the noble gas argon of the catalytic and thrombolytic efficiency of tissue plasminogen activator.

Authors:  Hélène N David; Benoît Haelewyn; Jean-Jacques Risso; Jacques H Abraini
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-11-11       Impact factor: 3.000

5.  Argon neuroprotection.

Authors:  Robert D Sanders; Daqing Ma; Mervyn Maze
Journal:  Crit Care       Date:  2010-02-22       Impact factor: 9.097

Review 6.  Bench-to-bedside review: Molecular pharmacology and clinical use of inert gases in anesthesia and neuroprotection.

Authors:  Robert Dickinson; Nicholas P Franks
Journal:  Crit Care       Date:  2010-08-12       Impact factor: 9.097

7.  Delayed argon administration provides robust protection against cardiac arrest-induced neurological damage.

Authors:  Anne Brücken; Pinar Kurnaz; Christian Bleilevens; Matthias Derwall; Joachim Weis; Kay Nolte; Rolf Rossaint; Michael Fries
Journal:  Neurocrit Care       Date:  2015-02       Impact factor: 3.210

8.  Ultrasound Responsive Noble Gas Microbubbles for Applications in Image-Guided Gas Delivery.

Authors:  Rajarshi Chattaraj; Misun Hwang; Serge D Zemerov; Ivan J Dmochowski; Daniel A Hammer; Daeyeon Lee; Chandra M Sehgal
Journal:  Adv Healthc Mater       Date:  2020-03-24       Impact factor: 9.933

9.  Mapping Hydrophobic Tunnels and Cavities in Neuroglobin with Noble Gas under Pressure.

Authors:  Nathalie Colloc'h; Philippe Carpentier; Laura C Montemiglio; Beatrice Vallone; Thierry Prangé
Journal:  Biophys J       Date:  2017-11-03       Impact factor: 4.033

10.  Argon: neuroprotection in in vitro models of cerebral ischemia and traumatic brain injury.

Authors:  Philip D Loetscher; Jan Rossaint; Rolf Rossaint; Joachim Weis; Michael Fries; Astrid Fahlenkamp; Yu-Mi Ryang; Oliver Grottke; Mark Coburn
Journal:  Crit Care       Date:  2009-12-17       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.